Meet Doreen

Doreen

Doreen, a school psychologist, is the mother of two boys and a girl. Adam is 19, Zachary is 12, and Taylor is 14. Both boys have severe hemophilia A, which was diagnosed at birth. Although Doreen has a nephew with hemophilia, she is not aware of any history in previous generations. Prior to getting pregnant, Doreen was tested and learned she is a carrier.

"Hemophilia isn't number one in our lives. It doesn't run our entire lives. Hemophilia is a little hiccup in the day-to-day activities that you have to address as needed or ahead of time through planning..."

Read Doreen’s stories.
Summer Camp: A Safe Bet
A Whole New World
Gettin’ in the Game
Straight Up: The Mix2Vial Needle-Free Transfer Device
The Perfect Mother’s Day
Forging a Lasting Friendship
Challenges in Arranging Childcare
Home Infusion and Sports
Overcoming the Isolation of Living in a Rural Area
Adam Playing Contact Sports
Summer Activities

Helixatefs.com

Important Safety Information for Helixate^®FS

Helixate^® FS is a recombinant factor VIII (FVIII) product used to treat hemophilia A when there is a demonstrated deficiency of FVIII, a plasma clotting factor.

Helixate^® FS should be administered cautiously in patients with previous hypersensitivity to constituents of FVIII preparations of known sensitivity to mouse or hamster protein.

Adverse events are generally minor. The most common adverse events include injection-site reactions, dizziness, and rash.

For more information about Helixate^® FS, please see full Prescribing Information.